A detailed history of Personal Capital Advisors Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Personal Capital Advisors Corp holds 35,598 shares of ILMN stock, worth $5.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
35,598
Previous 32,832 8.42%
Holding current value
$5.09 Million
Previous $6.26 Million 14.89%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $517,905 - $671,418
2,766 Added 8.42%
35,598 $7.2 Million
Q3 2022

Nov 07, 2022

BUY
$177.23 - $227.44 $2.85 Million - $3.66 Million
16,094 Added 96.15%
32,832 $6.26 Million
Q2 2022

Aug 04, 2022

SELL
$181.58 - $368.0 $3.21 Million - $6.51 Million
-17,691 Reduced 51.38%
16,738 $3.09 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $3.25 Million - $4.53 Million
10,696 Added 45.07%
34,429 $12 Million
Q4 2021

Feb 11, 2022

SELL
$347.28 - $421.83 $559,815 - $679,989
-1,612 Reduced 6.36%
23,733 $9.06 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $896,803 - $1.16 Million
2,211 Added 9.56%
25,345 $10.3 Million
Q2 2021

Aug 11, 2021

BUY
$372.84 - $481.5 $2.25 Million - $2.91 Million
6,048 Added 35.4%
23,134 $10.9 Million
Q1 2021

May 14, 2021

BUY
$361.28 - $504.76 $2.64 Million - $3.69 Million
7,312 Added 74.81%
17,086 $6.56 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $121,763 - $154,319
416 Added 4.45%
9,774 $3.62 Million
Q3 2020

Nov 13, 2020

BUY
$268.51 - $400.74 $386,922 - $577,466
1,441 Added 18.2%
9,358 $2.89 Million
Q2 2020

Aug 12, 2020

BUY
$256.46 - $373.01 $2.03 Million - $2.95 Million
7,917 New
7,917 $2.93 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Personal Capital Advisors Corp Portfolio

Follow Personal Capital Advisors Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.